Close
ACHEMA MIDDLE EAST 2026

Sanofi Drug Components Venture Comes To Life After Two Years

It's a fact: EUROAPI debuted on the Euronext exchange two years and one pandemic after Sanofi announced plans to sell off its European pharma...

Quality Issues Lead To Novartis Halting Cancer Radiotherapy

Novartis has halted production of its two commercial radioligand treatments for cancer care just weeks after the FDA approved them. Novartis confirmed on May 5th...

FDA Regulates Use of J&J COVID Jab Due To Risk Of Thrombosis

The US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be restricted to people 18...

Multiply Labs Partners To Automate Cell Therapy Production

Multiply Labs is equipping itself with two additional pieces of industry-leading tech in its quest to automate manual elements of the cell therapy production...

Amphista and BMS partner to develop protein degradation therapies

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, today announced a strategic collaboration with...

Catalent Acquires Commercial-Scale Cell Therapy Development and Manufacturing Facility in Princeton, New Jersey, from Erytech

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across...

Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells

Pluristyx, Inc., an advanced therapy tools and services biotechnology company, and Accelerated Biosciences, a regenerative medicine innovator in the use of proprietary human trophoblast...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...